by Annabel Sedgwick
Share
by Annabel Sedgwick
Share
Scientific Laboratory Supplies (SLS), the UK’s largest independent supplier of scientific products, is pleased to announce further consolidation of its relationship with Merck through its appointment as an official distributor for the Supelco® range of analytical products. Comprising of over 500,000 products, the comprehensive range from SLS provides a solution for most applications.
The Supelco brand incorporates many of the product lines that have made Merck one of the key names in the analytical laboratory sector, from chromatography and spectroscopy to solvents and reference standards, as well as titration and almost any other analytical chemistry technique. The Supelco brand also includes many of the products previously known as Merck products.
SLS has over 30 years of experience supporting the UK scientific sector and, as a strategic partner for Merck, this arrangement consolidates a commitment by both companies to high quality products and services, manufacturing effectiveness and meeting customers’ expectations. SLS also offers next day delivery on all in-stock products.
In the fast-paced world of routine lab testing, easy, secure and reliable transfer of data for method execution and documentation is essential. Supelco digital solutions can help make daily analytical work safer, simpler and more efficient, to ensure the most accurate results.
Being able to offer these market-leading Supelco products alongside the entire Merck Sigma-Aldrich portfolio strengthens our market position, and allows our customers access to these leading brands from a single source.”
SLS has grown to become the UK’s largest independent supplier of laboratory equipment, chemicals, and consumables.
For more information, go to www.scientificlabs.co.uk.
Microban® International – the global leader in antimicrobial additives and odor control solutions – has released a statement discrediting unwarranted claims about the safety and efficacy of antimicrobial technologies. This statement is intended to ensure that the public, consumers, and other stakeholders are equipped to make fully informed decisions, based on scientific reasoning. Making a clear distinction between public health and non-public health claims, Microban has explained the advantages of incorporating its antimicrobial additives into
Anion dysregulation is seen in numerous diseases, from cystic fibrosis and chronic pain, to autism and cancer. Researchers at the University of Dallas are investigating anion transport in vivo, developing novel tools to help analyze the effects of both normal and aberrant anion regulation at the molecular level, and are using INTEGRA’s PIPETBOY acu 2 to streamline their cell
June Medical is one of 48 organisations to be recognised for their excellence in innovation in this year’s Queen’s Awards for Enterprise. Now in its 55th year, the Queen’s Awards for Enterprise are the most prestigious business awards in the country – rewarding only the most outstanding achievements – with winning businesses able to use the esteemed
A report from the International Agency for Research on Cancer1 recently classified TiO2 as ‘possibly carcinogenic to humans’ by inhalation and similarly, the European Chemicals Agency2 recommended TiO2 be classified as a category 2 carcinogen (suspected of causing cancer). In contrast, antimicrobial technologies from Microban International are based on SilverShield®, the first patented antimicrobial solution